EA035360B1 - Способы трансдифференцировки и способы их использования - Google Patents

Info

Publication number

EA035360B1

EA035360B1 EA201791508A EA201791508A EA035360B1 EA 035360 B1 EA035360 B1 EA 035360B1 EA 201791508 A EA201791508 A EA 201791508A EA 201791508 A EA201791508 A EA 201791508A EA 035360 B1 EA035360 B1 EA 035360B1

Authority

EA

Eurasian Patent Office

Prior art keywords

cells

expression

cell

insulin

another embodiment

Prior art date

2014-12-30

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 201
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 328
• 108090001061 Insulin Proteins 0.000 claims abstract description 167
• 229940125396 insulin Drugs 0.000 claims abstract description 165
• 102000004877 Insulin Human genes 0.000 claims abstract description 164
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 141
• 239000008103 glucose Substances 0.000 claims abstract description 139
• 230000001105 regulatory effect Effects 0.000 claims abstract description 68
• 230000001965 increasing effect Effects 0.000 claims abstract description 54
• PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims abstract description 40
• 101000976075 Homo sapiens Insulin Proteins 0.000 claims abstract description 39
• 238000004519 manufacturing process Methods 0.000 claims abstract description 33
• 230000028327 secretion Effects 0.000 claims abstract description 30
• 210000004027 cell Anatomy 0.000 claims description 1036
• 230000014509 gene expression Effects 0.000 claims description 238
• 102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 claims description 134
• 210000005229 liver cell Anatomy 0.000 claims description 132
• 101710144033 Pancreas/duodenum homeobox protein 1 Proteins 0.000 claims description 117
• 150000007523 nucleic acids Chemical class 0.000 claims description 111
• 102000040945 Transcription factor Human genes 0.000 claims description 106
• 108091023040 Transcription factor Proteins 0.000 claims description 106
• 102000039446 nucleic acids Human genes 0.000 claims description 105
• 108020004707 nucleic acids Proteins 0.000 claims description 105
• 230000003914 insulin secretion Effects 0.000 claims description 75
• 208000015181 infectious disease Diseases 0.000 claims description 61
• 239000013598 vector Substances 0.000 claims description 59
• 239000013604 expression vector Substances 0.000 claims description 47
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 43
• 102000005396 glutamine synthetase Human genes 0.000 claims description 41
• 108020002326 glutamine synthetase Proteins 0.000 claims description 41
• 101150075928 Pax4 gene Proteins 0.000 claims description 39
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 39
• 229920001184 polypeptide Polymers 0.000 claims description 37
• 210000001519 tissue Anatomy 0.000 claims description 36
• 210000004185 liver Anatomy 0.000 claims description 35
• 230000004913 activation Effects 0.000 claims description 32
• 108060003199 Glucagon Proteins 0.000 claims description 31
• 210000002237 B-cell of pancreatic islet Anatomy 0.000 claims description 27
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 27
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims description 27
• 229960004666 glucagon Drugs 0.000 claims description 27
• 229910052744 lithium Inorganic materials 0.000 claims description 27
• 210000005228 liver tissue Anatomy 0.000 claims description 27
• VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 claims description 24
• 238000012545 processing Methods 0.000 claims description 24
• 108010075254 C-Peptide Proteins 0.000 claims description 22
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 17
• 230000004156 Wnt signaling pathway Effects 0.000 claims description 17
• 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 17
• 230000003247 decreasing effect Effects 0.000 claims description 16
• 230000001537 neural effect Effects 0.000 claims description 16
• 230000005014 ectopic expression Effects 0.000 claims description 9
• 102100037241 Endoglin Human genes 0.000 claims description 8
• 101000881679 Homo sapiens Endoglin Proteins 0.000 claims description 8
• 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 8
• 210000003494 hepatocyte Anatomy 0.000 claims description 8
• 230000006698 induction Effects 0.000 claims description 8
• 102100022464 5'-nucleotidase Human genes 0.000 claims description 7
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims description 7
• 101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims description 7
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 7
• 108091027981 Response element Proteins 0.000 claims description 7
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 7
• 210000002919 epithelial cell Anatomy 0.000 claims description 7
• 102100025422 Bone morphogenetic protein receptor type-2 Human genes 0.000 claims description 6
• 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 claims description 6
• 101000955481 Homo sapiens Phosphatidylcholine translocator ABCB4 Proteins 0.000 claims description 6
• 102100032818 Integrin alpha-4 Human genes 0.000 claims description 6
• 102100039032 Phosphatidylcholine translocator ABCB4 Human genes 0.000 claims description 6
• 102100036034 Thrombospondin-1 Human genes 0.000 claims description 6
• 210000005260 human cell Anatomy 0.000 claims description 6
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 claims description 5
• 102100034452 Alternative prion protein Human genes 0.000 claims description 5
• 102100032912 CD44 antigen Human genes 0.000 claims description 5
• 101000924727 Homo sapiens Alternative prion protein Proteins 0.000 claims description 5
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 5
• 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims description 5
• 101000573901 Homo sapiens Major prion protein Proteins 0.000 claims description 5
• 101000612089 Homo sapiens Pancreas/duodenum homeobox protein 1 Proteins 0.000 claims description 5
• 210000002950 fibroblast Anatomy 0.000 claims description 5
• 101000659879 Homo sapiens Thrombospondin-1 Proteins 0.000 claims description 4
• 102100032816 Integrin alpha-6 Human genes 0.000 claims description 4
• 210000000577 adipose tissue Anatomy 0.000 claims description 4
• 210000001185 bone marrow Anatomy 0.000 claims description 4
• 210000002889 endothelial cell Anatomy 0.000 claims description 4
• 210000002826 placenta Anatomy 0.000 claims description 4
• 210000003491 skin Anatomy 0.000 claims description 4
• 210000003954 umbilical cord Anatomy 0.000 claims description 4
• 102100028098 Homeobox protein Nkx-6.1 Human genes 0.000 claims description 3
• 208000016222 Pancreatic disease Diseases 0.000 claims description 3
• 102000027316 Vesicle-associated membrane protein 4 Human genes 0.000 claims description 3
• 108091013883 Vesicle-associated membrane protein 4 Proteins 0.000 claims description 3
• 210000000601 blood cell Anatomy 0.000 claims description 3
• 210000001671 embryonic stem cell Anatomy 0.000 claims description 3
• 230000002708 enhancing effect Effects 0.000 claims description 3
• 210000004700 fetal blood Anatomy 0.000 claims description 3
• 108010046722 Thrombospondin 1 Proteins 0.000 claims description 2
• 210000003897 hepatic stem cell Anatomy 0.000 claims description 2
• 235000015110 jellies Nutrition 0.000 claims description 2
• 239000008274 jelly Substances 0.000 claims description 2
• 210000000663 muscle cell Anatomy 0.000 claims description 2
• 208000024691 pancreas disease Diseases 0.000 claims description 2
• 210000004991 placental stem cell Anatomy 0.000 claims description 2
• 210000004927 skin cell Anatomy 0.000 claims description 2
• 210000004748 cultured cell Anatomy 0.000 claims 3
• 108050008407 Bone morphogenetic protein receptor type-2 Proteins 0.000 claims 2
• 102100025222 CD63 antigen Human genes 0.000 claims 2
• 102100023607 Homer protein homolog 1 Human genes 0.000 claims 2
• 101001017818 Homo sapiens ATP-dependent translocase ABCB1 Proteins 0.000 claims 2
• 108010009489 Lysosomal-Associated Membrane Protein 3 Proteins 0.000 claims 2
• 102400000321 Glucagon Human genes 0.000 claims 1
• 101710147597 Homer protein homolog 1 Proteins 0.000 claims 1
• 101001048469 Homo sapiens Homer protein homolog 1 Proteins 0.000 claims 1
• 108091000054 Prion Proteins 0.000 claims 1
• 102000029797 Prion Human genes 0.000 claims 1
• 210000002798 bone marrow cell Anatomy 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 210000004989 spleen cell Anatomy 0.000 claims 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 137
• 101100129232 Danio rerio mafaa gene Proteins 0.000 description 114
• 101150051019 Klrg1 gene Proteins 0.000 description 114
• 101150084866 MAFA gene Proteins 0.000 description 114
• 108090000623 proteins and genes Proteins 0.000 description 95
• 238000011282 treatment Methods 0.000 description 76
• 238000003306 harvesting Methods 0.000 description 58
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 54
• 230000008569 process Effects 0.000 description 46
• 108010056088 Somatostatin Proteins 0.000 description 44
• 238000002474 experimental method Methods 0.000 description 42
• 101100351017 Mus musculus Pax4 gene Proteins 0.000 description 39
• 101710164463 Preterminal protein Proteins 0.000 description 39
• 230000006870 function Effects 0.000 description 39
• 102000004169 proteins and genes Human genes 0.000 description 38
• 230000004044 response Effects 0.000 description 38
• 102000005157 Somatostatin Human genes 0.000 description 37
• 210000000496 pancreas Anatomy 0.000 description 36
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 36
• 229960000553 somatostatin Drugs 0.000 description 36
• 235000018102 proteins Nutrition 0.000 description 35
• 230000035899 viability Effects 0.000 description 33
• 230000000694 effects Effects 0.000 description 32
• 102000053602 DNA Human genes 0.000 description 31
• 108020004414 DNA Proteins 0.000 description 31
• 241000700605 Viruses Species 0.000 description 31
• 101100519293 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pdx-1 gene Proteins 0.000 description 30
• 102100024392 Insulin gene enhancer protein ISL-1 Human genes 0.000 description 29
• 206010012601 diabetes mellitus Diseases 0.000 description 29
• 230000035800 maturation Effects 0.000 description 29
• -1 NeuroDl Proteins 0.000 description 28
• 241000701161 unidentified adenovirus Species 0.000 description 28
• 102000051325 Glucagon Human genes 0.000 description 27
• 238000010899 nucleation Methods 0.000 description 27
• 101100096242 Mus musculus Sox9 gene Proteins 0.000 description 25
• 102000052651 Pancreatic hormone Human genes 0.000 description 23
• 239000000203 mixture Substances 0.000 description 23
• 239000004025 pancreas hormone Substances 0.000 description 23
• 229940032957 pancreatic hormone Drugs 0.000 description 23
• 108050003627 Wnt Proteins 0.000 description 22
• 102000013814 Wnt Human genes 0.000 description 22
• 101000613495 Homo sapiens Paired box protein Pax-4 Proteins 0.000 description 21
• 150000001875 compounds Chemical class 0.000 description 21
• 230000007423 decrease Effects 0.000 description 21
• 239000003814 drug Substances 0.000 description 21
• 102100040909 Paired box protein Pax-4 Human genes 0.000 description 20
• 238000004458 analytical method Methods 0.000 description 20
• 238000000338 in vitro Methods 0.000 description 20
• 101150070110 Isl1 gene Proteins 0.000 description 17
• 210000004962 mammalian cell Anatomy 0.000 description 17
• 230000011664 signaling Effects 0.000 description 17
• 229940124597 therapeutic agent Drugs 0.000 description 17
• 101710183548 Pyridoxal 5'-phosphate synthase subunit PdxS Proteins 0.000 description 16
• 230000007717 exclusion Effects 0.000 description 16
• 238000003127 radioimmunoassay Methods 0.000 description 16
• 238000003757 reverse transcription PCR Methods 0.000 description 16
• 108091006299 SLC2A2 Proteins 0.000 description 15
• 229920002477 rna polymer Polymers 0.000 description 15
• 108010088751 Albumins Proteins 0.000 description 14
• 102000009027 Albumins Human genes 0.000 description 14
• 239000003795 chemical substances by application Substances 0.000 description 14
• 230000001225 therapeutic effect Effects 0.000 description 14
• 108060000903 Beta-catenin Proteins 0.000 description 13
• 102000015735 Beta-catenin Human genes 0.000 description 13
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 13
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 13
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 13
• 238000003556 assay Methods 0.000 description 13
• 230000003833 cell viability Effects 0.000 description 13
• 239000000523 sample Substances 0.000 description 13
• 108010085238 Actins Proteins 0.000 description 12
• 101001053263 Homo sapiens Insulin gene enhancer protein ISL-1 Proteins 0.000 description 12
• 108700020479 Pancreatic hormone Proteins 0.000 description 12
• 239000002299 complementary DNA Substances 0.000 description 12
• 230000018109 developmental process Effects 0.000 description 12
• 238000001415 gene therapy Methods 0.000 description 12
• 238000011534 incubation Methods 0.000 description 12
• 108020004999 messenger RNA Proteins 0.000 description 12
• 230000007170 pathology Effects 0.000 description 12
• 238000001890 transfection Methods 0.000 description 12
• 101800001268 Pancreatic hormone Proteins 0.000 description 11
• 238000004113 cell culture Methods 0.000 description 11
• 238000001727 in vivo Methods 0.000 description 11
• 238000002347 injection Methods 0.000 description 11
• 239000007924 injection Substances 0.000 description 11
• 239000000463 material Substances 0.000 description 11
• 239000013603 viral vector Substances 0.000 description 11
• 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 10
• 206010033645 Pancreatitis Diseases 0.000 description 10
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
• 238000002659 cell therapy Methods 0.000 description 10
• 238000004520 electroporation Methods 0.000 description 10
• 239000012634 fragment Substances 0.000 description 10
• 239000005090 green fluorescent protein Substances 0.000 description 10
• 229940088597 hormone Drugs 0.000 description 10
• 239000005556 hormone Substances 0.000 description 10
• 230000001939 inductive effect Effects 0.000 description 10
• 238000002360 preparation method Methods 0.000 description 10
• 238000012360 testing method Methods 0.000 description 10
• 238000002560 therapeutic procedure Methods 0.000 description 10
• 102100037732 Neuroendocrine convertase 2 Human genes 0.000 description 9
• 101150106167 SOX9 gene Proteins 0.000 description 9
• 210000004369 blood Anatomy 0.000 description 9
• 239000008280 blood Substances 0.000 description 9
• 238000005516 engineering process Methods 0.000 description 9
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 9
• 201000001421 hyperglycemia Diseases 0.000 description 9
• 239000002609 medium Substances 0.000 description 9
• 210000002569 neuron Anatomy 0.000 description 9
• 239000000047 product Substances 0.000 description 9
• 230000002829 reductive effect Effects 0.000 description 9
• 239000000243 solution Substances 0.000 description 9
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
• 230000003213 activating effect Effects 0.000 description 8
• 150000001413 amino acids Chemical class 0.000 description 8
• 238000001574 biopsy Methods 0.000 description 8
• 238000011161 development Methods 0.000 description 8
• 230000004069 differentiation Effects 0.000 description 8
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
• 238000000605 extraction Methods 0.000 description 8
• 230000002440 hepatic effect Effects 0.000 description 8
• 239000002502 liposome Substances 0.000 description 8
• 238000003259 recombinant expression Methods 0.000 description 8
• 210000000130 stem cell Anatomy 0.000 description 8
• 230000003612 virological effect Effects 0.000 description 8
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 7
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 7
• 108091028043 Nucleic acid sequence Proteins 0.000 description 7
• 208000036142 Viral infection Diseases 0.000 description 7
• 238000001514 detection method Methods 0.000 description 7
• 238000010586 diagram Methods 0.000 description 7
• 239000003937 drug carrier Substances 0.000 description 7
• 210000004153 islets of langerhan Anatomy 0.000 description 7
• 230000001404 mediated effect Effects 0.000 description 7
• 230000008672 reprogramming Effects 0.000 description 7
• 239000011780 sodium chloride Substances 0.000 description 7
• 238000013518 transcription Methods 0.000 description 7
• 230000035897 transcription Effects 0.000 description 7
• 238000012546 transfer Methods 0.000 description 7
• 230000001052 transient effect Effects 0.000 description 7
• 230000009385 viral infection Effects 0.000 description 7
• 102100037985 Dickkopf-related protein 3 Human genes 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• 241000588724 Escherichia coli Species 0.000 description 6
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 6
• 101000951342 Homo sapiens Dickkopf-related protein 3 Proteins 0.000 description 6
• 101000601394 Homo sapiens Neuroendocrine convertase 2 Proteins 0.000 description 6
• 206010028980 Neoplasm Diseases 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 230000000735 allogeneic effect Effects 0.000 description 6
• 230000000692 anti-sense effect Effects 0.000 description 6
• 230000027455 binding Effects 0.000 description 6
• 230000033228 biological regulation Effects 0.000 description 6
• 230000010261 cell growth Effects 0.000 description 6
• 230000001413 cellular effect Effects 0.000 description 6
• 201000010099 disease Diseases 0.000 description 6
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 6
• 229940088598 enzyme Drugs 0.000 description 6
• 238000002955 isolation Methods 0.000 description 6
• 239000008194 pharmaceutical composition Substances 0.000 description 6
• 230000035755 proliferation Effects 0.000 description 6
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 210000003462 vein Anatomy 0.000 description 6
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
• 238000002965 ELISA Methods 0.000 description 5
• 101000971533 Homo sapiens Killer cell lectin-like receptor subfamily G member 1 Proteins 0.000 description 5
• 101000979205 Homo sapiens Transcription factor MafA Proteins 0.000 description 5
• 239000005089 Luciferase Substances 0.000 description 5
• 241000699670 Mus sp. Species 0.000 description 5
• 241000283973 Oryctolagus cuniculus Species 0.000 description 5
• 102100023237 Transcription factor MafA Human genes 0.000 description 5
• 108090000631 Trypsin Proteins 0.000 description 5
• 102000004142 Trypsin Human genes 0.000 description 5
• 239000003242 anti bacterial agent Substances 0.000 description 5
• 238000013459 approach Methods 0.000 description 5
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 238000009395 breeding Methods 0.000 description 5
• 230000001488 breeding effect Effects 0.000 description 5
• 230000004663 cell proliferation Effects 0.000 description 5
• 230000006378 damage Effects 0.000 description 5
• 230000001747 exhibiting effect Effects 0.000 description 5
• 239000012091 fetal bovine serum Substances 0.000 description 5
• 239000001963 growth medium Substances 0.000 description 5
• 239000004615 ingredient Substances 0.000 description 5
• 238000001990 intravenous administration Methods 0.000 description 5
• OGQSCIYDJSNCMY-UHFFFAOYSA-H iron(3+);methyl-dioxido-oxo-$l^{5}-arsane Chemical compound [Fe+3].[Fe+3].C[As]([O-])([O-])=O.C[As]([O-])([O-])=O.C[As]([O-])([O-])=O OGQSCIYDJSNCMY-UHFFFAOYSA-H 0.000 description 5
• 238000003670 luciferase enzyme activity assay Methods 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 239000011859 microparticle Substances 0.000 description 5
• 125000003729 nucleotide group Chemical group 0.000 description 5
• 239000001301 oxygen Substances 0.000 description 5
• 229910052760 oxygen Inorganic materials 0.000 description 5
• 230000004203 pancreatic function Effects 0.000 description 5
• 239000013612 plasmid Substances 0.000 description 5
• 238000003908 quality control method Methods 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 230000003248 secreting effect Effects 0.000 description 5
• 230000003068 static effect Effects 0.000 description 5
• 230000004936 stimulating effect Effects 0.000 description 5
• 238000003860 storage Methods 0.000 description 5
• 238000001356 surgical procedure Methods 0.000 description 5
• 230000008685 targeting Effects 0.000 description 5
• 238000010361 transduction Methods 0.000 description 5
• 230000026683 transduction Effects 0.000 description 5
• 239000012588 trypsin Substances 0.000 description 5
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
• 108010011459 Exenatide Proteins 0.000 description 4
• 102000030595 Glucokinase Human genes 0.000 description 4
• 108010021582 Glucokinase Proteins 0.000 description 4
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
• 241000238631 Hexapoda Species 0.000 description 4
• 101000934635 Homo sapiens Bone morphogenetic protein receptor type-2 Proteins 0.000 description 4
• 101000923090 Homo sapiens Homeobox protein ARX Proteins 0.000 description 4
• 101000604998 Homo sapiens Lysosome-associated membrane glycoprotein 3 Proteins 0.000 description 4
• 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 4
• 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 4
• 102100038213 Lysosome-associated membrane glycoprotein 3 Human genes 0.000 description 4
• DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 4
• 108010076181 Proinsulin Proteins 0.000 description 4
• 238000000692 Student's t-test Methods 0.000 description 4
• 229960003942 amphotericin b Drugs 0.000 description 4
• 239000000427 antigen Substances 0.000 description 4
• 108091007433 antigens Proteins 0.000 description 4
• 102000036639 antigens Human genes 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 210000004271 bone marrow stromal cell Anatomy 0.000 description 4
• 238000004422 calculation algorithm Methods 0.000 description 4
• 239000000969 carrier Substances 0.000 description 4
• JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 4
• 238000000576 coating method Methods 0.000 description 4
• 238000013270 controlled release Methods 0.000 description 4
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
• 239000006185 dispersion Substances 0.000 description 4
• 230000008030 elimination Effects 0.000 description 4
• 238000003379 elimination reaction Methods 0.000 description 4
• 210000003890 endocrine cell Anatomy 0.000 description 4
• 230000007705 epithelial mesenchymal transition Effects 0.000 description 4
• 210000003527 eukaryotic cell Anatomy 0.000 description 4
• 229960001519 exenatide Drugs 0.000 description 4
• 238000000684 flow cytometry Methods 0.000 description 4
• 230000004927 fusion Effects 0.000 description 4
• 102000037865 fusion proteins Human genes 0.000 description 4
• 108020001507 fusion proteins Proteins 0.000 description 4
• 238000001476 gene delivery Methods 0.000 description 4
• 238000009396 hybridization Methods 0.000 description 4
• 238000003125 immunofluorescent labeling Methods 0.000 description 4
• 230000001771 impaired effect Effects 0.000 description 4
• 230000003834 intracellular effect Effects 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 238000012544 monitoring process Methods 0.000 description 4
• 239000002773 nucleotide Substances 0.000 description 4
• 201000002528 pancreatic cancer Diseases 0.000 description 4
• 208000008443 pancreatic carcinoma Diseases 0.000 description 4
• 230000009996 pancreatic endocrine effect Effects 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 210000001236 prokaryotic cell Anatomy 0.000 description 4
• 230000010076 replication Effects 0.000 description 4
• 230000001177 retroviral effect Effects 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 239000003826 tablet Substances 0.000 description 4
• 230000002123 temporal effect Effects 0.000 description 4
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 3
• 108020005544 Antisense RNA Proteins 0.000 description 3
• 241000894006 Bacteria Species 0.000 description 3
• WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
• 102100030074 Dickkopf-related protein 1 Human genes 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 102100027043 Discoidin, CUB and LCCL domain-containing protein 2 Human genes 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 108700014808 Homeobox Protein Nkx-2.2 Proteins 0.000 description 3
• 102100028096 Homeobox protein Nkx-6.2 Human genes 0.000 description 3
• 108010077223 Homer Scaffolding Proteins Proteins 0.000 description 3
• 102000010029 Homer Scaffolding Proteins Human genes 0.000 description 3
• 101000864646 Homo sapiens Dickkopf-related protein 1 Proteins 0.000 description 3
• 101000911787 Homo sapiens Discoidin, CUB and LCCL domain-containing protein 2 Proteins 0.000 description 3
• 101000578258 Homo sapiens Homeobox protein Nkx-6.2 Proteins 0.000 description 3
• 101000603702 Homo sapiens Neurogenin-3 Proteins 0.000 description 3
• 241000713666 Lentivirus Species 0.000 description 3
• 108060001084 Luciferase Proteins 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 206010028813 Nausea Diseases 0.000 description 3
• 208000012902 Nervous system disease Diseases 0.000 description 3
• 108050000588 Neurogenic differentiation factor 1 Proteins 0.000 description 3
• 102100032063 Neurogenic differentiation factor 1 Human genes 0.000 description 3
• 102100038553 Neurogenin-3 Human genes 0.000 description 3
• 208000025966 Neurological disease Diseases 0.000 description 3
• 102000007354 PAX6 Transcription Factor Human genes 0.000 description 3
• 102100026450 POU domain, class 3, transcription factor 4 Human genes 0.000 description 3
• 101710133389 POU domain, class 3, transcription factor 4 Proteins 0.000 description 3
• 229930182555 Penicillin Natural products 0.000 description 3
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
• 108090000545 Proprotein Convertase 2 Proteins 0.000 description 3
• 108090000544 Proprotein convertase 1 Proteins 0.000 description 3
• 102000004085 Proprotein convertase 1 Human genes 0.000 description 3
• 238000011529 RT qPCR Methods 0.000 description 3
• 108700008625 Reporter Genes Proteins 0.000 description 3
• 108010017324 STAT3 Transcription Factor Proteins 0.000 description 3
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
• 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• 239000004480 active ingredient Substances 0.000 description 3
• 230000001464 adherent effect Effects 0.000 description 3
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 235000014633 carbohydrates Nutrition 0.000 description 3
• 230000015556 catabolic process Effects 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 239000011248 coating agent Substances 0.000 description 3
• 239000003184 complementary RNA Substances 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 238000005138 cryopreservation Methods 0.000 description 3
• 230000002950 deficient Effects 0.000 description 3
• 238000006731 degradation reaction Methods 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 239000003085 diluting agent Substances 0.000 description 3
• 239000002612 dispersion medium Substances 0.000 description 3
• 238000009826 distribution Methods 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 230000002124 endocrine Effects 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 239000012530 fluid Substances 0.000 description 3
• 239000007789 gas Substances 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 208000004104 gestational diabetes Diseases 0.000 description 3
• 230000003394 haemopoietic effect Effects 0.000 description 3
• 238000003018 immunoassay Methods 0.000 description 3
• 238000010166 immunofluorescence Methods 0.000 description 3
• 230000002458 infectious effect Effects 0.000 description 3
• 238000001802 infusion Methods 0.000 description 3
• 238000007914 intraventricular administration Methods 0.000 description 3
• 238000011031 large-scale manufacturing process Methods 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 238000001638 lipofection Methods 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 238000012317 liver biopsy Methods 0.000 description 3
• 238000002493 microarray Methods 0.000 description 3
• 238000010369 molecular cloning Methods 0.000 description 3
• 230000008693 nausea Effects 0.000 description 3
• 230000004770 neurodegeneration Effects 0.000 description 3
• 208000015122 neurodegenerative disease Diseases 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 210000004940 nucleus Anatomy 0.000 description 3
• 230000005305 organ development Effects 0.000 description 3
• 230000037361 pathway Effects 0.000 description 3
• 229940049954 penicillin Drugs 0.000 description 3
• 102000040430 polynucleotide Human genes 0.000 description 3
• 108091033319 polynucleotide Proteins 0.000 description 3
• 239000002157 polynucleotide Substances 0.000 description 3
• 210000003240 portal vein Anatomy 0.000 description 3
• 239000000843 powder Substances 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 230000001737 promoting effect Effects 0.000 description 3
• 230000035945 sensitivity Effects 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 238000007619 statistical method Methods 0.000 description 3
• 229960005322 streptomycin Drugs 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 230000009885 systemic effect Effects 0.000 description 3
• ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 230000010474 transient expression Effects 0.000 description 3
• 241000701447 unidentified baculovirus Species 0.000 description 3
• 230000004580 weight loss Effects 0.000 description 3
• 208000016261 weight loss Diseases 0.000 description 3
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 208000035404 Autolysis Diseases 0.000 description 2
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
• 108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 2
• 102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• 102000000844 Cell Surface Receptors Human genes 0.000 description 2
• 206010057248 Cell death Diseases 0.000 description 2
• 208000000668 Chronic Pancreatitis Diseases 0.000 description 2
• 102000029816 Collagenase Human genes 0.000 description 2
• 108060005980 Collagenase Proteins 0.000 description 2
• 241000701022 Cytomegalovirus Species 0.000 description 2
• 101100518002 Danio rerio nkx2.2a gene Proteins 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
• 102000001267 GSK3 Human genes 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 description 2
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
• 102100031470 Homeobox protein ARX Human genes 0.000 description 2
• 102100027886 Homeobox protein Nkx-2.2 Human genes 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
• 101100460496 Homo sapiens NKX2-2 gene Proteins 0.000 description 2
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
• 101000639146 Homo sapiens Vesicle-associated membrane protein 4 Proteins 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• 102100022338 Integrin alpha-M Human genes 0.000 description 2
• 206010023126 Jaundice Diseases 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 101100516510 Mus musculus Neurog3 gene Proteins 0.000 description 2
• 108010032788 PAX6 Transcription Factor Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 206010033649 Pancreatitis chronic Diseases 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 102000006437 Proprotein Convertases Human genes 0.000 description 2
• 108010044159 Proprotein Convertases Proteins 0.000 description 2
• 208000003251 Pruritus Diseases 0.000 description 2
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
• 108010016283 TCF Transcription Factors Proteins 0.000 description 2
• 102000000479 TCF Transcription Factors Human genes 0.000 description 2
• 206010043458 Thirst Diseases 0.000 description 2
• 102100031489 Vesicle-associated membrane protein 4 Human genes 0.000 description 2
• 206010047513 Vision blurred Diseases 0.000 description 2
• 206010047700 Vomiting Diseases 0.000 description 2
• 230000003187 abdominal effect Effects 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 208000009956 adenocarcinoma Diseases 0.000 description 2
• 210000004504 adult stem cell Anatomy 0.000 description 2
• 230000003698 anagen phase Effects 0.000 description 2
• 230000000844 anti-bacterial effect Effects 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 229940121375 antifungal agent Drugs 0.000 description 2
• 239000003429 antifungal agent Substances 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 235000010323 ascorbic acid Nutrition 0.000 description 2
• 229960005070 ascorbic acid Drugs 0.000 description 2
• 239000011668 ascorbic acid Substances 0.000 description 2
• 239000012298 atmosphere Substances 0.000 description 2
• 230000002238 attenuated effect Effects 0.000 description 2
• 210000003719 b-lymphocyte Anatomy 0.000 description 2
• WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 2
• 108010005774 beta-Galactosidase Proteins 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 210000004413 cardiac myocyte Anatomy 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 230000011748 cell maturation Effects 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 239000006285 cell suspension Substances 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 238000011260 co-administration Methods 0.000 description 2
• 230000004186 co-expression Effects 0.000 description 2
• 230000008045 co-localization Effects 0.000 description 2
• 229960002424 collagenase Drugs 0.000 description 2
• 230000009260 cross reactivity Effects 0.000 description 2
• 230000002354 daily effect Effects 0.000 description 2
• 230000003412 degenerative effect Effects 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 208000035475 disorder Diseases 0.000 description 2
• 230000009977 dual effect Effects 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 238000005538 encapsulation Methods 0.000 description 2
• 206010016256 fatigue Diseases 0.000 description 2
• 235000019197 fats Nutrition 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 230000004190 glucose uptake Effects 0.000 description 2
• 229930195712 glutamate Natural products 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 235000011187 glycerol Nutrition 0.000 description 2
• 230000005484 gravity Effects 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 230000003054 hormonal effect Effects 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 238000010185 immunofluorescence analysis Methods 0.000 description 2
• 239000007943 implant Substances 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000004054 inflammatory process Effects 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 208000014674 injury Diseases 0.000 description 2
• 238000010253 intravenous injection Methods 0.000 description 2
• 239000007951 isotonicity adjuster Substances 0.000 description 2
• 230000007803 itching Effects 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 239000010410 layer Substances 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000003211 malignant effect Effects 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 239000003094 microcapsule Substances 0.000 description 2
• 230000027939 micturition Effects 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 210000001178 neural stem cell Anatomy 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 230000000926 neurological effect Effects 0.000 description 2
• 229960003966 nicotinamide Drugs 0.000 description 2
• 235000005152 nicotinamide Nutrition 0.000 description 2
• 239000011570 nicotinamide Substances 0.000 description 2
• 239000000346 nonvolatile oil Substances 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 210000000277 pancreatic duct Anatomy 0.000 description 2
• 230000002085 persistent effect Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 239000000825 pharmaceutical preparation Substances 0.000 description 2
• 235000021317 phosphate Nutrition 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 230000001902 propagating effect Effects 0.000 description 2
• 238000002731 protein assay Methods 0.000 description 2
• 230000022558 protein metabolic process Effects 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 238000000275 quality assurance Methods 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 230000010837 receptor-mediated endocytosis Effects 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000006798 recombination Effects 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 230000028043 self proteolysis Effects 0.000 description 2
• 210000002325 somatostatin-secreting cell Anatomy 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 238000010257 thawing Methods 0.000 description 2
• 230000001131 transforming effect Effects 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 230000008673 vomiting Effects 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• 239000002699 waste material Substances 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• 210000005253 yeast cell Anatomy 0.000 description 2
• OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 1
• ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• 101150090724 3 gene Proteins 0.000 description 1
• 208000004998 Abdominal Pain Diseases 0.000 description 1
• 206010000087 Abdominal pain upper Diseases 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 206010001258 Adenoviral infections Diseases 0.000 description 1
• 208000010370 Adenoviridae Infections Diseases 0.000 description 1
• 206010060931 Adenovirus infection Diseases 0.000 description 1
• 208000007848 Alcoholism Diseases 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 206010003402 Arthropod sting Diseases 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 239000002028 Biomass Substances 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 240000001432 Calendula officinalis Species 0.000 description 1
• 235000005881 Calendula officinalis Nutrition 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 102000005403 Casein Kinases Human genes 0.000 description 1
• 108010031425 Casein Kinases Proteins 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 108010051219 Cre recombinase Proteins 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
• 241000252212 Danio rerio Species 0.000 description 1
• 101000923091 Danio rerio Aristaless-related homeobox protein Proteins 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
• 239000012983 Dulbecco’s minimal essential medium Substances 0.000 description 1
• 108091035710 E-box Proteins 0.000 description 1
• 108010013369 Enteropeptidase Proteins 0.000 description 1
• 102100029727 Enteropeptidase Human genes 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 108010045438 Frizzled receptors Proteins 0.000 description 1
• 102000005698 Frizzled receptors Human genes 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108090001126 Furin Proteins 0.000 description 1
• 102000027587 GPCRs class F Human genes 0.000 description 1
• 108091008884 GPCRs class F Proteins 0.000 description 1
• 101100180045 Gallus gallus ISL1 gene Proteins 0.000 description 1
• 102400000921 Gastrin Human genes 0.000 description 1
• 108010052343 Gastrins Proteins 0.000 description 1
• 206010018404 Glucagonoma Diseases 0.000 description 1
• 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
• 241000288105 Grus Species 0.000 description 1
• 102000006354 HLA-DR Antigens Human genes 0.000 description 1
• 108010058597 HLA-DR Antigens Proteins 0.000 description 1
• 241000034673 Holographis Species 0.000 description 1
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
• 101100518189 Homo sapiens PDHX gene Proteins 0.000 description 1
• 101100519290 Homo sapiens PDX1 gene Proteins 0.000 description 1
• 101000632994 Homo sapiens Somatostatin Proteins 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• 241000701109 Human adenovirus 2 Species 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• 208000013016 Hypoglycemia Diseases 0.000 description 1
• 208000001953 Hypotension Diseases 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102100025304 Integrin beta-1 Human genes 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 108010015167 Low Density Lipoprotein Receptor-Related Protein-5 Proteins 0.000 description 1
• 102100021926 Low-density lipoprotein receptor-related protein 5 Human genes 0.000 description 1
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 244000246386 Mentha pulegium Species 0.000 description 1
• 235000016257 Mentha pulegium Nutrition 0.000 description 1
• 235000004357 Mentha x piperita Nutrition 0.000 description 1
• 108700011259 MicroRNAs Proteins 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 102000008763 Neurofilament Proteins Human genes 0.000 description 1
• 108010088373 Neurofilament Proteins Proteins 0.000 description 1
• 101710096141 Neurogenin-3 Proteins 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108091005461 Nucleic proteins Chemical group 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 101150081664 PAX6 gene Proteins 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 206010033627 Pancreatic injury Diseases 0.000 description 1
• 206010033635 Pancreatic pseudocyst Diseases 0.000 description 1
• 206010033647 Pancreatitis acute Diseases 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 229920001710 Polyorthoester Polymers 0.000 description 1
• 229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 1
• 241001417524 Pomacanthidae Species 0.000 description 1
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
• 102000006478 Protein Phosphatase 2 Human genes 0.000 description 1
• 108010058956 Protein Phosphatase 2 Proteins 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 208000001647 Renal Insufficiency Diseases 0.000 description 1
• 102000012083 SOX9 Transcription Factor Human genes 0.000 description 1
• 108010036426 SOX9 Transcription Factor Proteins 0.000 description 1
• 102000001712 STAT5 Transcription Factor Human genes 0.000 description 1
• 108010029477 STAT5 Transcription Factor Proteins 0.000 description 1
• 208000006504 Scorpion Stings Diseases 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108010048349 Steroidogenic Factor 1 Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 206010042674 Swelling Diseases 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 1
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 102000014104 Transcription factor MafA Human genes 0.000 description 1
• 108050003977 Transcription factor MafA Proteins 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• 239000012840 University of Wisconsin (UW) solution Substances 0.000 description 1
• 239000005862 Whey Substances 0.000 description 1
• 102000007544 Whey Proteins Human genes 0.000 description 1
• 108010046377 Whey Proteins Proteins 0.000 description 1
• 102000044880 Wnt3A Human genes 0.000 description 1
• 108700013515 Wnt3A Proteins 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
• 208000020560 abdominal swelling Diseases 0.000 description 1
• 238000002679 ablation Methods 0.000 description 1
• 239000003070 absorption delaying agent Substances 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 208000006336 acinar cell carcinoma Diseases 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 201000003229 acute pancreatitis Diseases 0.000 description 1
• 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 206010001584 alcohol abuse Diseases 0.000 description 1
• 208000025746 alcohol use disease Diseases 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 230000036528 appetite Effects 0.000 description 1
• 235000019789 appetite Nutrition 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 230000006470 autoimmune attack Effects 0.000 description 1
• 239000013602 bacteriophage vector Substances 0.000 description 1
• 230000003385 bacteriostatic effect Effects 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 235000019445 benzyl alcohol Nutrition 0.000 description 1
• 239000003613 bile acid Substances 0.000 description 1
• 239000003833 bile salt Substances 0.000 description 1
• 229940093761 bile salts Drugs 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 229920000249 biocompatible polymer Polymers 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 238000009534 blood test Methods 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 230000014461 bone development Effects 0.000 description 1
• 208000029028 brain injury Diseases 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000007910 cell fusion Effects 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 238000013189 cholangiography Methods 0.000 description 1
• 201000001883 cholelithiasis Diseases 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 210000001612 chondrocyte Anatomy 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 235000019504 cigarettes Nutrition 0.000 description 1
• 150000001860 citric acid derivatives Chemical class 0.000 description 1
• 238000000975 co-precipitation Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 238000002591 computed tomography Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 208000002445 cystadenocarcinoma Diseases 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000001934 delay Effects 0.000 description 1
• 108700041286 delta Proteins 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 230000002542 deteriorative effect Effects 0.000 description 1
• 229960002086 dextran Drugs 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 229940079919 digestives enzyme preparation Drugs 0.000 description 1
• UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 230000002183 duodenal effect Effects 0.000 description 1
• 235000013399 edible fruits Nutrition 0.000 description 1
• 101150097231 eg gene Proteins 0.000 description 1
• 230000013020 embryo development Effects 0.000 description 1
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
• 238000007459 endoscopic retrograde cholangiopancreatography Methods 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 230000008995 epigenetic change Effects 0.000 description 1
• 210000003999 epithelial cell of bile duct Anatomy 0.000 description 1
• 210000004955 epithelial membrane Anatomy 0.000 description 1
• 235000020774 essential nutrients Nutrition 0.000 description 1
• 239000005038 ethylene vinyl acetate Substances 0.000 description 1
• 230000003203 everyday effect Effects 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• 108010021843 fluorescent protein 583 Proteins 0.000 description 1
• 102000034287 fluorescent proteins Human genes 0.000 description 1
• 108091006047 fluorescent proteins Proteins 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 235000021588 free fatty acids Nutrition 0.000 description 1
• IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
• 208000001130 gallstones Diseases 0.000 description 1
• 208000015419 gastrin-producing neuroendocrine tumor Diseases 0.000 description 1
• 201000000052 gastrinoma Diseases 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 238000012252 genetic analysis Methods 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 239000008241 heterogeneous mixture Substances 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 235000001050 hortel pimenta Nutrition 0.000 description 1
• 102000052072 human NEUROG3 Human genes 0.000 description 1
• 102000045305 human SST Human genes 0.000 description 1
• 235000003642 hunger Nutrition 0.000 description 1
• 230000002218 hypoglycaemic effect Effects 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000002991 immunohistochemical analysis Methods 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
• 239000003701 inert diluent Substances 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 238000013383 initial experiment Methods 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 239000013546 insoluble monolayer Substances 0.000 description 1
• 206010022498 insulinoma Diseases 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 210000004347 intestinal mucosa Anatomy 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 238000005184 irreversible process Methods 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 201000006370 kidney failure Diseases 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 239000004973 liquid crystal related substance Substances 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 208000012866 low blood pressure Diseases 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 201000001240 maturity-onset diabetes of the young type 9 Diseases 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
• 229940012189 methyl orange Drugs 0.000 description 1
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
• 229960001047 methyl salicylate Drugs 0.000 description 1
• 229960002216 methylparaben Drugs 0.000 description 1
• 239000000693 micelle Substances 0.000 description 1
• 239000002679 microRNA Substances 0.000 description 1
• 238000010208 microarray analysis Methods 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000011785 micronutrient Substances 0.000 description 1
• 235000013369 micronutrients Nutrition 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 210000002200 mouth mucosa Anatomy 0.000 description 1
• 239000002324 mouth wash Substances 0.000 description 1
• 229940051866 mouthwash Drugs 0.000 description 1
• 210000004400 mucous membrane Anatomy 0.000 description 1
• 108010050062 mutacin GS-5 Proteins 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 239000006218 nasal suppository Substances 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 210000005044 neurofilament Anatomy 0.000 description 1
• 230000003955 neuronal function Effects 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 239000002687 nonaqueous vehicle Substances 0.000 description 1
• 230000008779 noncanonical pathway Effects 0.000 description 1
• 238000012758 nuclear staining Methods 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 231100000590 oncogenic Toxicity 0.000 description 1
• 230000002246 oncogenic effect Effects 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 1
• 230000015031 pancreas development Effects 0.000 description 1
• 108700011804 pancreatic and duodenal homeobox 1 Proteins 0.000 description 1
• 208000021255 pancreatic insulinoma Diseases 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 210000001778 pluripotent stem cell Anatomy 0.000 description 1
• 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 239000008389 polyethoxylated castor oil Substances 0.000 description 1
• 239000004633 polyglycolic acid Substances 0.000 description 1
• 239000004626 polylactic acid Substances 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 235000015277 pork Nutrition 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000003334 potential effect Effects 0.000 description 1
• 230000035935 pregnancy Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
• 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 238000001525 receptor binding assay Methods 0.000 description 1
• 230000010656 regulation of insulin secretion Effects 0.000 description 1
• 230000001718 repressive effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 229910052702 rhenium Inorganic materials 0.000 description 1
• WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 229940081974 saccharin Drugs 0.000 description 1
• 235000019204 saccharin Nutrition 0.000 description 1
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 229930182490 saponin Natural products 0.000 description 1
• 150000007949 saponins Chemical class 0.000 description 1
• 238000013341 scale-up Methods 0.000 description 1
• 210000004739 secretory vesicle Anatomy 0.000 description 1
• 238000005204 segregation Methods 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 239000012679 serum free medium Substances 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 230000022379 skeletal muscle tissue development Effects 0.000 description 1
• 230000012488 skeletal system development Effects 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 238000009331 sowing Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 238000003153 stable transfection Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 150000005846 sugar alcohols Polymers 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 238000012353 t test Methods 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229960004906 thiomersal Drugs 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 238000011200 topical administration Methods 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 108091006106 transcriptional activators Proteins 0.000 description 1
• 108091006108 transcriptional coactivators Proteins 0.000 description 1
• 238000003151 transfection method Methods 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000009495 transient activation Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 238000001291 vacuum drying Methods 0.000 description 1
• 238000009777 vacuum freeze-drying Methods 0.000 description 1
• ATCJTYORYKLVIA-SRXJVYAUSA-N vamp regimen Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1.C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C(C45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 ATCJTYORYKLVIA-SRXJVYAUSA-N 0.000 description 1
• 239000002435 venom Substances 0.000 description 1
• 210000001048 venom Anatomy 0.000 description 1
• 231100000611 venom Toxicity 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 239000008215 water for injection Substances 0.000 description 1
• 238000002689 xenotransplantation Methods 0.000 description 1
• 238000013316 zoning Methods 0.000 description 1